March 28th 2019
Genetic Technologies benefits from Healthy China Policy
March 21st 2019
Gophr restructure to boost profits at Auctus
Imugene gains guidance for KEY-Vaxx Immunotherapy development
March 14th 2019
First patient dosed in phase 2 trial with Imugene’s gastric cancer vaccine
March 4th 2019
Imugene to present cancer vaccine programs to the American Association for Cancer Research
February 28th 2019
Cashed up Imugene to present at American Association for Cancer Research
February 19th 2019
Hemp demand sees Elixinol fly high with outstanding revenue growth
January 21st 2019
Antisense Phase II Clinical Trial now 50% enrolled and on track for completion
January 9th 2019
BPH sharpens up brain monitoring & medical marijuana efforts
January 7th 2019
Imugene onboards renowned cancer scientist Michael Caligiuri
December 17th 2018
Imugene's promising trial results: five patients with >30% decrease in tumour size
December 7th 2018
RotoGro buzzes on new strategic Affinity
Connect with us
Subscribe to our weekly wrap.
Thanks for subscribing!
